The design of potent Pin1 inhibitors has been challenging because its active site specifically recognizes a phospho-protein epitope. The de novo design of phosphate-based Pin1 inhibitors focusing on the phosphate recognition pocket and the successful replacement of the phosphate group with a carboxylate have been previously reported. The potency of the carboxylate series is now further improved through structure-based optimization of ligand-protein interactions in the proline binding site which exploits the H-bond interactions necessary for Pin1 catalytic function. Further optimization using a focused library approach led to the discovery of low nanomolar non-phosphate small molecular Pin1 inhibitors. Structural modifications designed to improve cell permeability resulted in Pin1 inhibitors with low micromolar anti-proliferative activities against cancer cells.
Keywords: Anti-cancer; Anti-tumor; Cell permeability; Medicinal chemistry; Mitosis; PPIase; Peptidyl-prolyl isomerase; Phospho-protein epitope; Pin1; SBDD; Structural based drug design.
Copyright © 2014 Elsevier Ltd. All rights reserved.